AZTR

$0.25-0.01 (-3.75%)

Pre-Market$0.25-0.00 (-0.32%)· Last close May 5

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO